Needham & Company downgraded Achaogen (NASDAQ: AKAO) from Buy to Hold.Analyst Alan Carr comments "Achaogen hosted a quarterly conference call ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE